The next five to 10 years will see more opportunities for personalized screening & intervention for #BreastCancer. A recent trial by @UCSF_Ci2 & @UCSFimaging's Dr. Maggie Chung & @UCBerkeley's Adam Yala is contributing to expediated patient care. t.co/EgkjskYSvv t.co/BJVBvjjIyU